Memorial Sloan-Kettering's 30th annual Academic Convocation honored students receiving PhD degrees for work conducted in Memorial Sloan-Kettering's laboratories; younger Memorial Sloan-Kettering physicians, scientists, and postdoctoral research fellows; and established clinicians and investigators from the Center and beyond.
Memorial Sloan-Kettering's 30th annual Academic Convocation featured a stirring address by Freeman A. Hrabowski, III, President of the University of Maryland, Baltimore County.
To address the special challenges of treating cancer in older patients, Memorial Sloan-Kettering recently established a Geriatrics Service in the Department of Medicine.
Michael Overholtzer is a recent recruit to Sloan-Kettering Institute's Cell Biology Program, he pairs this curiosity with a dedication to finding new ways to control disease.
A team of researchers led by Memorial Sloan-Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.
More than 100 Memorial Sloan-Kettering investigators shared their latest findings with oncologists from around the world at the annual meeting of the American Society of Clinical Oncology, which was held in Orlando May 29 through June 2.
Each year, during ASCO's annual meeting, the ASCO Foundation recognizes oncologists who are in different stages of their careers for major achievements or proven commitment to clinical research. This year, eight Memorial Sloan-Kettering Cancer Center investigators were honored with ASCO grants.
Patients operated on for gastrointestinal stromal tumors live longer without their disease coming back if they receive the drug imatinib (Gleevec®) as an adjuvant therapy after surgery.
Memorial Sloan-Kettering President Harold Varmus joined lawmakers, scientists, and patients on March 9 at a White House ceremony as President Barack Obama issued an executive order lifting the strict limits on human embryonic stem cell research.
Dinshaw J. Patel, a Member in Sloan-Kettering Institute's Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.
Richard J. O'Reilly, Chair of Memorial Sloan-Kettering's Department of Pediatrics and Chief of the Pediatric Bone Marrow Transplant Service, received the John P. McGovern Compleat Physician Award from the Harris County (Texas) Medical Society and the Houston Academy of Medicine.
Memorial Sloan-Kettering's Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan-Kettering Institute's Grégoire Altan-Bonnet and Songhai Shi.
Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan-Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.
John P. Mulhall has been affiliated with Memorial Sloan-Kettering's Urology Service since 2003 and has now been appointed Director of the Male Sexual and Reproductive Medicine Program.
Gerald A. Soff has joined Memorial Sloan-Kettering as Director of the Benign Hematology Program in the Department of Medicine and a member of the Hematology Disease Management Team.